Evidence map›Paper›PMID 39081124›Full record

ArticleDrug testing and analysis2025

High-throughput liquid chromatography-vacuum differential mobility spectrometry-mass spectrometry for the analysis of isomeric drugs of abuse in human urine.

Maria Fernanda Cifuentes Girard, Patrick Knight, Gérard Hopfgartner

Abstract read
In one paragraph

Article in Drug testing and analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Interpol review of forensic toxicology, 2023-2025.Forensic science international. Synergy · 2026
    Review
  2. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Fernanda Cifuentes GirardLife Sciences Mass Spectrometry, Department of Inorganic and Analytical Chemistry, University of Geneva, Geneva 4, Switzerland.ORCID https://orcid.org/0009-0000-5837-2657
Patrick KnightShimadzu Research Laboratory, Manchester, UK.ORCID https://orcid.org/0000-0003-0813-8760
Gérard HopfgartnerLife Sciences Mass Spectrometry, Department of Inorganic and Analytical Chemistry, University of Geneva, Geneva 4, Switzerland.ORCID https://orcid.org/0000-0002-9087-606X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of differential mobility spectrometry at low pressure coupled to liquid chromatography-mass spectrometry (LC-vDMS-MS) was investigated for the analysis of 13 drugs of abuse (DoA) including the following: cocaine, ecgonine methyl ester, cocaethylene, benzoylecgonine, norcocaine, tramadol, isomeric pairs of metabolites; O-desmethyl-cis-tramadol and N-desmethyl-cis-tramadol, and cannabinoids: Δ

Indexed as

High-Throughput Screening AssaysIllicit DrugsMass SpectrometrySubstance Abuse DetectionCannabinoidsChromatography, LiquidHumansIsomerismLimit of DetectionTandem Mass SpectrometryCannabinoidsIllicit Drugsdifferential mobility spectrometryliquid chromatographymass spectrometryurine drugs of abuse

Identifiers

PMID39081124
PMCPMC12151711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.